Targeting chromatin remodeling complexes to treat uveal melanoma.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 41024709.
- Also identified by DOI 10.7554/eLife.109262 and PMC identifier 12483503.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
A novel compound that inhibits the BAF chromatin remodeling complex causes regression in an animal model of the incurable cancer uveal melanoma.
Medical subject headings
- Uveal Neoplasms
- Melanoma
- Chromatin Assembly and Disassembly
- Antineoplastic Agents